Legal aspects of newborn screening

Abstract

Newborn screening is used for the early detection of diseases in newborns and enables rapid intervention to prevent serious consequences, including infant death. Since the Genetic Diagnostics Act came into force in 2010, the rules of the Act have applied to newborn screening. Over the years since the Act came into force, some legal issues have been resolved, but new legal aspects have also arisen for which the Act does not yet provide a solution.